ghk-cu fda approved drug status for Anti-Aging: Does This Copper Peptide Really Work? FDA Committee Votes to Ease

It upregulates actin, promoting cell migration and tissue repair across the entire body

Safety & Tolerability

Mistake 2: Insufficient protein intake The aggressive appetite suppression from four metabolic pathways can make eating feel like a chore

This is an off-label combination that has not been studied directly

Conclusion: A Dual Path With Encouraging Direction GHK-Cu's unique dual-track regulatory path topical from Category 1 and injectable from Category 2, both heading to PCAC review before February 2027 reflects the complexity and nuance of the FDA's current approach to peptide regulation

No guesswork, just results